2012
DOI: 10.1016/j.biologicals.2012.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: State of the science and planning the way forward

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 53 publications
(19 citation statements)
references
References 22 publications
0
18
0
1
Order By: Relevance
“…In contrast, soluble monomeric glycoprotein G could not be quantified. As such, this ELISA complies with the requirements of the international workshop on alternative methods for human and veterinary rabies vaccine stating that the potency of rabies vaccines must be measured with a quantitative method specific for the virus-associated conformationally intact G protein [2].…”
Section: Discussionmentioning
confidence: 90%
See 3 more Smart Citations
“…In contrast, soluble monomeric glycoprotein G could not be quantified. As such, this ELISA complies with the requirements of the international workshop on alternative methods for human and veterinary rabies vaccine stating that the potency of rabies vaccines must be measured with a quantitative method specific for the virus-associated conformationally intact G protein [2].…”
Section: Discussionmentioning
confidence: 90%
“…All recommendations of the international workshop on alternative methods for human and veterinary rabies vaccine were fulfilled [2]. Because it targets well conformed non-linear epitopes of glycoprotein G involved in the induction of potent neutralizing antibodies, this ELISA could be used for in vitro quality control along process and as a potency test, avoiding the use of mice.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…For example, the global efforts between manufacturers of rabies vaccines for human and veterinary use, regulatory agencies, National Institutes of Health (NIH), and several organizations to replace the in vivo potency test (called "NIH test") used to release these vaccines by in vitro alternative methods consistent with 3Rs principles of animal testing (Replacement, Reduction and Refinement) (Stokes et al 2012). Some ongoing or recent approaches are promising.…”
Section: Challenges In Lot Releasementioning
confidence: 99%